- KASL clinical practice guidelines: management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363029
- Clin Mol Hepatol.
- 2016 Mar;22(1):18-75.
- doi: 10.3350/cmh.2016.22.1.18
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation of HBV DNA Level and Viral Breakthrough During Lamivudine Therapy for Chronic Hepatitis B
-
Park HS, Lee DH, Heo J, Kim GH, Kang DH, Song GA, Cho M
- KMID: 760644
- Korean J Hepatol.
- 2006 Jun;12(2):173-183.
BACKGROUND/AIMS: Lamivudine is an effective therapy in chronic hepatitis B patients, but the emergence of resistant hepatitis B virus (HBV) mutants is a major concern. This study was performed... -
- CITED
-
- Close
- SHARE
-
- Close
- HBV DNA Loss within 24 Weeks Predicts Late Viral Breakthrough in Chronic Hepatitis B
-
Jeon SR, Jang JY, Jeong SW, Park SH, Lee SH, Kim SG, Cheon YK, Kim YS, Cho YD, Moon JH, Kim HS, Lee JS, Kim BS
- KMID: 1792811
- Korean J Gastroenterol.
- 2011 Jul;58(1):25-30.
- doi: 10.4166/kjg.2011.58.1.25
BACKGROUND/AIMS: Sustained HBV DNA reduction is necessary for biochemical remission, histological improvement, and prevention of complications. We analyzed the time taken from HBV DNA loss to viral breakthrough after antiviral... -
- CITED
-
- Close
- SHARE
-
- Close
- New perspectives of biomarkers for the management of chronic hepatitis B
-
Lin CL, Kao JH
- KMID: 2373145
- Clin Mol Hepatol.
- 2016 Dec;22(4):423-431.
- doi: 10.3350/cmh.2016.0069
With recent advances in molecular and genomic investigations, the impact of hepatitis B viral and host factors on the progression of chronic HBV infection has been explored. For viral factors,... -
- CITED
-
- Close
- SHARE
-
- Close
- KASL Clinical Practice Guidelines: Management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 1743722
- Clin Mol Hepatol.
- 2012 Jun;18(2):109-162.
- doi: 10.3350/cmh.2012.18.2.109
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Risk stratification of HBV infection in Asia-Pacific region
-
Kao JH
- KMID: 2069757
- Clin Mol Hepatol.
- 2014 Sep;20(3):223-227.
- doi: 10.3350/cmh.2014.20.3.223
Hepatitis B virus (HBV) infection is the major etiology of chronic liver disease worldwide and thus a global health problem, especially in Asia-Pacific region. The long-term outcomes of Asian HBV... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Meaning of the Emergence of Viral Breakthrough during Lamivudine Treatment in Patients with Hepatitis B Virus Related Chronic Liver Disease
-
Park CB, Lim HJ, Yun BC, Lee SU, Han BH
- KMID: 760538
- Korean J Hepatol.
- 2004 Jun;10(2):108-116.
BACKGROUND/AIMS: Viral breakthrough has been considered a major limitation of lamivudine in the treatment of hepatitis B virus related chronic liver disease. Its clinical meaning has not been thoroughly... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA
-
Kim DH, Choi JW, Seo JH, Cho YS, Won SY, Park BK, Jeon HH, Shin SY, Lee CK
- KMID: 2419112
- Yonsei Med J.
- 2017 May;58(3):552-556.
- doi: 10.3349/ymj.2017.58.3.552
PURPOSE: This study examined 2-year outcome of consecutive therapy using entecavir (ETV) followed by telbivudine (LdT) in subjects with undetectable hepatitis B virus (HBV) DNA level and normal alanine aminotransferase... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Hepatitis B Surface Antigen Quantification in Chronic Hepatitis B
-
Yeon JE
- KMID: 2234033
- Korean J Gastroenterol.
- 2014 Jun;63(6):335-340.
- doi: 10.4166/kjg.2014.63.6.335
Since the discovery of HBsAg in the early 1960s, presence of HBsAg in serum has only served to diagnose hepatitis B. Recent development in the quantitative measurement of serum HBsAg... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
-
Jo YJ, Kim KA, Lee JS, Kim NH, Bae WK, Song TJ, Kim JW
- KMID: 2160681
- Korean J Intern Med.
- 2015 Mar;30(2):170-176.
- doi: 10.3904/kjim.2015.30.2.170
BACKGROUND/AIMS: The clinical outcome of patients with a partial virological response (PVR) to entecavir (ETV), in particular nucloes(t)ide analogue (NA)-experienced patients, has not been thoroughly investigated. The aim of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of BiosewoomTM Real-Q Cytomegalovirus Quantification kit for Cytomegalovirus Viral Load Measure
-
Heo WB, Won DI, Kim YL, Kim MH, Oh HB, Suh JS
- KMID: 1781500
- Korean J Lab Med.
- 2007 Aug;27(4):298-304.
- doi: 10.3343/kjlm.2007.27.4.298
BACKGROUND: Rapid and accurate laboratory tests are essential to detect cytomegalovirus (CMV) infections in solid organs and haematopoietic stem cell transplant recipients. We assessed the realtime quantitative PCR (RQ-PCR)... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure
-
Lee CI, Kwon SY, Kim JH, Choe WH, Lee CH, Yoon EL, Yeon JE, Byun KS, Kim YS, Kim JH
- KMID: 1774530
- Gut Liver.
- 2014 Jan;8(1):64-69.
BACKGROUND/AIMS: We investigated the efficacy and safety of tenofovir disoproxil fumarate (TDF)-based treatment in chronic hepatitis B (CHB) patients who failed previous antiviral therapies. METHODS: Seventeen patients who failed to achieve... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B
-
Kim IH, Kim SH, Kim HC, Shin KD, Kim SW, Lee SO, Lee ST, Kim DG
- KMID: 760736
- Korean J Hepatol.
- 2007 Sep;13(3):349-362.
- doi: 10.3350/kjhep.2007.13.3.349
BACKGROUND/AIMS: Adefovir dipivoxil (ADV) resistance in patients with lamivudine-resistant chronic hepatitis B is not well understood. This study examined the initial virologic response (IVR) to ADV, the rate of... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Factors and Clinical Outcome of Viral Breakthrough during Lamivudine Treatment for Chronic Hepatitis B Infection
-
Park NH, Shin JW, Park JH, Bang SJ, Kim DH, Joo KR, Kim DH
- KMID: 1085302
- Korean J Hepatol.
- 2003 Dec;9(4):293-303.
BACKGROUND/AIMS: Long-term treatment with lamivudine causes breakthrough, but the clinical course after lamivudine breakthrough is not well known. The aims of this study were to evaluate the clinical course... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Severe Chronic Active Epstein-Barr Virus Infection with Aplastic Anemia and Hepatitis
-
Lee JI, Lee SW, Han NI, Ro SM, Noh YS, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 2373392
- Korean J Gastroenterol.
- 2016 Jan;67(1):39-43.
- doi: 10.4166/kjg.2016.67.1.39
Epstein-Barr virus (EBV) causes various acute and chronic diseases. Chronic active EBV infection (CAEBV) is characterized by infectious mononucleosis-like symptoms that persist for more than 6 months with high viral... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
-
Kim HJ, Cho JY, Kim YJ, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH
- KMID: 2129661
- Korean J Intern Med.
- 2015 Jan;30(1):32-41.
- doi: 10.3904/kjim.2015.30.1.32
BACKGROUND/AIMS: The efficacy of tenofovir disoproxil fumarate (TDF) for the treatment of chronic hepatitis B (CHB) patients following prior treatment failure with multiple nucleos(t)ide analogues (NAs) is not well defined,... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Clevudine Resistance after Switching from Lamivudine in a Patient with Chronic Hepatitis B
-
Koh KH, Kang CJ, Kim DH, Choi YW, Kim MJ, Cheong JY, Cho SW
- KMID: 783106
- Korean J Gastroenterol.
- 2008 Nov;52(5):325-328.
Clevudine is a nucleoside analog of the unnatural beta-L configuration which has potent antiviral activity against hepatitis B virus (HBV). Clevudine is expected to have similar pattern of resistance profile... -
- CITED
-
- Close
- SHARE
-
- Close
- The Degrees of Hepatocyte Cytoplasmic Expression of Hepatitis B Core Antigen correlate with Histologic Activity of Liver Disease in the Young Patients with Chronic Hepatitis B Infection
-
Kim TH, Cho EY, Oh HJ, Choi CS, Kim JW, Moon HB, Kim HC
- KMID: 1781835
- J Korean Med Sci.
- 2006 Apr;21(2):279-283.
- doi: 10.3346/jkms.2006.21.2.279
Subcellular localizaton of HBcAg have been found to be related to the activity of liver disease and HBV replication. The aim of this study was to determine whether the degree... -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine Therapy for Korean Children with Chronic Hepatitis B
-
Koh H, Baek SY, Chung KS
- KMID: 1786205
- Yonsei Med J.
- 2007 Dec;48(6):927-933.
- doi: 10.3349/ymj.2007.48.6.927
PURPOSE: Lamivudine is known to be very effective in suppressing hepatitis B virus replication and virus induced necroinflammation. The aim of this study was to evaluate lamivudine therapy efficacy,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
-
Seo HY, Lee HA, Ko SY, Wang JH, Kim JH, Choe WH, Kwon SY
- KMID: 2413119
- Clin Mol Hepatol.
- 2017 Jun;23(2):154-159.
- doi: 10.3350/cmh.2016.0067
BACKGROUND/AIMS: Little is known about the effect of early flares on response during first-line tenofovir disoproxil fumarate (TDF) treatment for chronic hepatitis B (CHB). The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
